188 related articles for article (PubMed ID: 8941122)
1. Equipotent antihypertensive agents variously affect pulsatile hemodynamics and regression of cardiac hypertrophy in spontaneously hypertensive rats.
Mitchell GF; Pfeffer MA; Finn PV; Pfeffer JM
Circulation; 1996 Dec; 94(11):2923-9. PubMed ID: 8941122
[TBL] [Abstract][Full Text] [Related]
2. Role of cardiac hypertrophy in reducing the sensitivity of cardiopulmonary reflex control of renal sympathetic nerve activity in spontaneously hypertensive rats.
de Andrade TU; Abreu GR; Moysés MR; de Melo Cabral A; Bissoli NS
Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1104-8. PubMed ID: 18788121
[TBL] [Abstract][Full Text] [Related]
3. Reduced periinfarction mortality as a result of long-term therapy with captopril but not hydralazine or propranolol in spontaneously hypertensive rats.
Nguyen T; El Salibi E; Rouleau JL
J Cardiovasc Pharmacol; 1998 Dec; 32(6):884-95. PubMed ID: 9869493
[TBL] [Abstract][Full Text] [Related]
4. Chronic enalapril treatment increases transient outward potassium current in cardiomyocytes isolated from right ventricle of spontaneously hypertensive rats.
Rodrigues Junior LF; de Azevedo Carvalho AC; Pimentel EB; Mill JG; Nascimento JH
Naunyn Schmiedebergs Arch Pharmacol; 2017 Mar; 390(3):225-234. PubMed ID: 27915452
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular changes in spontaneously hypertensive rats are improved by chronic treatment with zofenopril.
Gómez-Roso M; Montero MJ; Carrón R; Sevilla MA
Br J Pharmacol; 2009 Dec; 158(8):1911-21. PubMed ID: 19917062
[TBL] [Abstract][Full Text] [Related]
6. Improvement in fatty acid utilization in relation to a change in left ventricular hypertrophy in spontaneously hypertensive rats.
Ono T; Kohya T; Tsukamoto E; Mochizuki T; Itoh K; Itoh Y; Tomita F; Tamaki N; Kitabatake A
Jpn Circ J; 2000 Feb; 64(2):117-20. PubMed ID: 10716525
[TBL] [Abstract][Full Text] [Related]
7. Role of lowering arterial pressure on maximal coronary flow with and without regression of cardiac hypertrophy.
Canby CA; Tomanek RJ
Am J Physiol; 1989 Oct; 257(4 Pt 2):H1110-8. PubMed ID: 2529781
[TBL] [Abstract][Full Text] [Related]
8. Reduced hemodynamic load aids low-dose resveratrol in reversing cardiovascular defects in hypertensive rats.
Thandapilly SJ; Louis XL; Behbahani J; Movahed A; Yu L; Fandrich R; Zhang S; Kardami E; Anderson HD; Netticadan T
Hypertens Res; 2013 Oct; 36(10):866-72. PubMed ID: 23784505
[TBL] [Abstract][Full Text] [Related]
9. Regression of cardiac hypertrophy after therapy in animal hypertension.
Motz W; Strauer BE
J Cardiovasc Pharmacol; 1985; 7 Suppl 2():S56-61. PubMed ID: 2409372
[TBL] [Abstract][Full Text] [Related]
10. Prevention of hypertensive hypertrophy by medical therapy: effects on systolic wall stress and systolic function.
Motz W; Strauer BE
Basic Res Cardiol; 1985; 80(6):642-52. PubMed ID: 2936329
[TBL] [Abstract][Full Text] [Related]
11. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
Jackson EK; Dubinion JH; Mi Z
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibrosis in stroke-prone spontaneously hypertensive rats.
Ikeda Y; Nakamura T; Takano H; Kimura H; Obata JE; Takeda S; Hata A; Shido K; Mochizuki S; Yoshida Y
J Lab Clin Med; 2000 Apr; 135(4):353-9. PubMed ID: 10779052
[TBL] [Abstract][Full Text] [Related]
13. Cardiac hypertrophy and characteristic impedance in spontaneously hypertensive rats.
Levy BI; Babalis D; Lacolley P; Poitevin P; Safar ME
J Hypertens Suppl; 1988 Dec; 6(4):S110-1. PubMed ID: 2977152
[TBL] [Abstract][Full Text] [Related]
14. Regression of ventricular hypertrophy abolishes cardiocyte vulnerability to acute hypoxia.
Canby CA; Tomanek RJ
Anat Rec; 1990 Feb; 226(2):198-206. PubMed ID: 2137307
[TBL] [Abstract][Full Text] [Related]
15. Prevention of the development of heart failure and the regression of cardiac hypertrophy by captopril in the spontaneously hypertensive rat.
Pfeffer JM; Pfeffer MA; Mirsky I; Braunwald E
Eur Heart J; 1983 Jan; 4 Suppl A():143-8. PubMed ID: 6220893
[TBL] [Abstract][Full Text] [Related]
16. Effects of lisinopril upon cardiac hypertrophy, central and peripheral hemodynamics and neurohumoral factors in spontaneously hypertensive rats.
Nishimura H; Kubota J; Okabe M; Ueyama M; Kawamura K
J Hypertens; 1992 May; 10(5):431-6. PubMed ID: 1317903
[TBL] [Abstract][Full Text] [Related]
17. [Effect of chronic antihypertensive treatment on ischemia-induced lethal ventricular tachyarrhythmias and electrophysiological property in hypertrophied rat hearts].
Yokoshiki H
Hokkaido Igaku Zasshi; 1993 Nov; 68(6):862-72. PubMed ID: 8112711
[TBL] [Abstract][Full Text] [Related]
18. Structural and functional adaptation in the rat myocardium and coronary vascular bed caused by changes in pressure and volume load.
Friberg P
Acta Physiol Scand Suppl; 1985; 540():1-47. PubMed ID: 3161269
[TBL] [Abstract][Full Text] [Related]
19. Chronic arterial vasodilation, central hemodynamics, and cardiac hypertrophy in spontaneously hypertensive rats.
Yuan B; Leenen FH
J Cardiovasc Pharmacol; 1992 Jun; 19(6):922-8. PubMed ID: 1376814
[TBL] [Abstract][Full Text] [Related]
20. Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in the spontaneously hypertensive rat.
Pfeffer JM; Pfeffer MA; Mirsky I; Braunwald E
Proc Natl Acad Sci U S A; 1982 May; 79(10):3310-4. PubMed ID: 6212929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
